The 2nd Edition of Cell & Gene Therapy Conference (CGTWC 2026) brings together global leaders from biotech, pharma, academia, physicians, investment firms, and regulatory agencies to accelerate the development, manufacturing, and commercialization of advanced cell and gene therapies (CGTs).

This event serves as a high-impact platform for clinical development, translational breakthroughs, scalable bioprocessing solutions, and strategic market growth discussions that define the future of cell and gene therapies. Our program is designed to go beyond scientific discovery, focusing on the practical, preclinical & clinical research, operational, regulatory, and commercial pathways required to bring transformative therapies to patients worldwide.

Highlights:

• Thematic Focus: Exploring ethics, efficacy, and societal impacts of cell and gene therapies.
• Keynote Sessions: Insights from researchers, clinicians, industry executives, and policymakers.
• Scientific Tracks: Gene editing and cellular engineering technologies, Clinical translation, and Regulatory and safety frameworks.
• Hands-On Workshops: Practical training on manufacturing, delivery systems, and editing techniques.
• Industry and Startup Showcase: Platform for biotech innovators, platform technology developers, and emerging startups to showcase their research findings.
• Strategic Panel Discussions: Expert-driven dialogues on accessibility, pricing & reimbursement models, and personalized medicine.
• Networking and Partnering Opportunities: Connect with experts, collaborators, and investors.
• Policy and Access Focus: Discussions on equitable access and sustainable development.
• Miami Location: Leverage the city’s world-class biotech ecosystem.
• Future-Oriented Agenda: Insights on emerging technologies, scalability, and global health strategies.